Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 140 pembrolizumab 119 Carboplatin 104 Bevacizumab 92 Cisplatin 67 Specimen Handling 63 Magnetic Resonance Spectroscopy 52 olaparib 51 Gemcitabine 39 Nivolumab 36 Biopsy 36 liposomal doxorubicin 32 Taxes 31 Cyclophosphamide 31 Blood Specimen Collection 29 niraparib 27 lenvatinib 26 Doxorubicin 26 Topotecan 25 Letrozole 25 Drug Therapy 25 Immunoglobulin G 22 fludarabine 21 atezolizumab 21 Radiotherapy 21 Brachytherapy 21 durvalumab 20 Surveys and Questionnaires 20 Disulfides 20 dostarlimab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glutamyl Aminopeptidase × Gynecologic × 1 year × Clear all

NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡